AllianceBernstein’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $183K | Buy |
58,830
+22,080
| +60% | +$68.7K | ﹤0.01% | 3071 |
|
|
2025
Q1 | $124K | Hold |
36,750
| – | – | ﹤0.01% | 3031 |
|
|
2024
Q4 | $208K | Hold |
36,750
| – | – | ﹤0.01% | 3018 |
|
|
2024
Q3 | $215K | Hold |
36,750
| – | – | ﹤0.01% | 3019 |
|
|
2024
Q2 | $291K | Buy |
36,750
+21,140
| +135% | +$167K | ﹤0.01% | 2920 |
|
|
2024
Q1 | $145K | Sell |
15,610
-6,320
| -29% | -$58.8K | ﹤0.01% | 2985 |
|
|
2023
Q4 | $185K | Hold |
21,930
| – | – | ﹤0.01% | 2996 |
|
|
2023
Q3 | $170K | Buy |
21,930
+2,690
| +14% | +$20.8K | ﹤0.01% | 2983 |
|
|
2023
Q2 | $220K | Buy |
+19,240
| New | +$220K | ﹤0.01% | 2954 |
|
|
2021
Q2 | – | Sell |
-32,000
| Closed | -$151K | – | 3401 |
|
|
2021
Q1 | $151K | Sell |
32,000
-5,000
| -14% | -$23.6K | ﹤0.01% | 3096 |
|
|
2020
Q4 | $265K | Hold |
37,000
| – | – | ﹤0.01% | 2904 |
|
|
2020
Q3 | $395K | Sell |
37,000
-1,400
| -4% | -$14.9K | ﹤0.01% | 2648 |
|
|
2020
Q2 | $485K | Buy |
38,400
+3,400
| +10% | +$42.9K | ﹤0.01% | 2623 |
|
|
2020
Q1 | $320K | Buy |
35,000
+5,100
| +17% | +$46.6K | ﹤0.01% | 2583 |
|
|
2019
Q4 | $417K | Hold |
29,900
| – | – | ﹤0.01% | 2610 |
|
|
2019
Q3 | $515K | Sell |
29,900
-4,800
| -14% | -$82.7K | ﹤0.01% | 2521 |
|
|
2019
Q2 | $945K | Buy |
34,700
+1,400
| +4% | +$38.1K | ﹤0.01% | 2329 |
|
|
2019
Q1 | $637K | Buy |
33,300
+3,900
| +13% | +$74.6K | ﹤0.01% | 2428 |
|
|
2018
Q4 | $276K | Buy |
29,400
+3,100
| +12% | +$29.1K | ﹤0.01% | 2763 |
|
|
2018
Q3 | $498K | Buy |
26,300
+2,500
| +11% | +$47.3K | ﹤0.01% | 2606 |
|
|
2018
Q2 | $465K | Buy |
23,800
+8,000
| +51% | +$156K | ﹤0.01% | 2630 |
|
|
2018
Q1 | $297K | Buy |
15,800
+3,100
| +24% | +$58.3K | ﹤0.01% | 2696 |
|
|
2017
Q4 | $211K | Buy |
12,700
+2,200
| +21% | +$36.6K | ﹤0.01% | 2840 |
|
|
2017
Q3 | $216K | Hold |
10,500
| – | – | ﹤0.01% | 2888 |
|
|
2017
Q2 | $94K | Buy |
+10,500
| New | +$94K | ﹤0.01% | 3076 |
|